BIT 3.85% 2.7¢ biotron limited

hcv trial success, page-6

  1. 1,843 Posts.
    Consider the implications for the HIV trial. These results provides the first proof of concept for what is potentially a platform drug with applications in a number of multi-billion dollar markets.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.6¢ 2.7¢ 2.6¢ $438 16.73K

Buyers (Bids)

No. Vol. Price($)
3 125551 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 157830 2
View Market Depth
Last trade - 12.25pm 15/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.